Close Menu

NEW YORK (GenomeWeb) – Agilent Technologies announced today that it has agreed to acquire Belgium-based molecular diagnostics developer Multiplicom for €68 million ($70.6 million) in cash.

The deal is expected to close in mid-January. All 90 Multiplicom employees will be offered jobs within Agilent, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.